Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Zuurstofsuppletie geen bijdrage na acute stroke
okt 2017 | Neuro-vasculair
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen